Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Haiech

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
BMC Cancer|February 26, 2010
CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumorsCristina Patru, Luciana Romao, Pascale Varlet, et al.
Antiviral Research|July 11, 2009
Identification of allosteric inhibitors blocking the hepatitis C virus polymerase NS5B in the RNA synthesis initiation stepStéphane Betzi, Cécilia Eydoux, Cécile Bussetta, et al.
Journal of Medicinal Chemistry|August 15, 2018
Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway HypereosinophiliaPierre Regenass, Dayana Abboud, François Daubeuf, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 23, 2017
Bisacodyl and its cytotoxic activity on human glioblastoma stem-like cells. Implication of inositol 1,4,5-triphosphate receptor dependent calcium signalingJihu Dong, Francisco J Aulestia, Suzana Assad Kahn, et al.
Plos One|August 14, 2015
Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like CellsMaria Zeniou, Marie Fève, Samir Mameri, et al.
The Journal of Biological Chemistry|June 17, 2008
Small neutralizing molecules to inhibit actions of the chemokine CXCL12Muriel Hachet-Haas, Karl Balabanian, François Rohmer, et al.
Acta Neuropathologica|November 18, 2017
Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressivenessAlexandra Bogeas, Ghislaine Morvan-Dubois, Elias A El-Habr, et al.
EMBO Molecular Medicine|May 4, 2016
The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ-dependent inhibition of the AKT pathwaySuzana Assad Kahn, Silvia Lima Costa, Sharareh Gholamin, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
BMC Cancer|February 26, 2010
CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumorsCristina Patru, Luciana Romao, Pascale Varlet, et al.
Antiviral Research|July 11, 2009
Identification of allosteric inhibitors blocking the hepatitis C virus polymerase NS5B in the RNA synthesis initiation stepStéphane Betzi, Cécilia Eydoux, Cécile Bussetta, et al.
Journal of Medicinal Chemistry|August 15, 2018
Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway HypereosinophiliaPierre Regenass, Dayana Abboud, François Daubeuf, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 23, 2017
Bisacodyl and its cytotoxic activity on human glioblastoma stem-like cells. Implication of inositol 1,4,5-triphosphate receptor dependent calcium signalingJihu Dong, Francisco J Aulestia, Suzana Assad Kahn, et al.
Plos One|August 14, 2015
Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like CellsMaria Zeniou, Marie Fève, Samir Mameri, et al.
The Journal of Biological Chemistry|June 17, 2008
Small neutralizing molecules to inhibit actions of the chemokine CXCL12Muriel Hachet-Haas, Karl Balabanian, François Rohmer, et al.
Acta Neuropathologica|November 18, 2017
Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressivenessAlexandra Bogeas, Ghislaine Morvan-Dubois, Elias A El-Habr, et al.
EMBO Molecular Medicine|May 4, 2016
The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ-dependent inhibition of the AKT pathwaySuzana Assad Kahn, Silvia Lima Costa, Sharareh Gholamin, et al.
Pageof 9